Clinical outcomes after aortic valve replacement with severe stenosis of trileaflet aortic valve and low valve calcium score.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
13 09 2023
Historique:
received: 26 01 2023
accepted: 22 05 2023
medline: 15 9 2023
pubmed: 9 6 2023
entrez: 8 6 2023
Statut: epublish

Résumé

Some patients have severe aortic valve stenosis (AS) despite a lower degree of aortic valve calcification (AVC). This study compared the clinical features and prognosis of patients undergoing aortic valve replacement (AVR) for severe AS with a low AVC score compared with those with higher AVC scores. This study included 1002 Korean patients with symptomatic severe degenerative AS who underwent AVR. We measured AVC score before AVR and defined low AVC as AVC score of <2000 units for male patients and <1300 units for female patients. Patients with bicuspid or rheumatic aortic valve disease were excluded. The mean age was 75.6±7.9 years and 487 patients (48.6%) were female. Mean left ventricular ejection fraction was 59.4%±10.4%, and concomitant coronary revascularisation was performed in 96 patients (9.6%). The median aortic valve calcium score was 3122 units (IQR 2249-4289 units) among male patients and 1756 units (IQR 1192-2572) among female patients. A total of 242 patients (24.2%) had low AVC; they were significantly younger (73.5±8.7 years vs 76.3±7.5 years, p<0.001) and were more likely to be female (59.5% vs 45.1%, p<0.001) and on haemodialysis (5.4% vs 1.8%, p=0.006) than those with high AVC. During a follow-up (median: 3.8 years), the patients with low AVC had significantly higher risk of death from any cause (adjusted HR 1.60, 95% CI 1.02 to 2.52, p=0.04), mostly non-cardiac cause. Patients with low AVC exhibit distinct clinical characteristics and a higher risk of long-term mortality compared with those with high AVC.

Sections du résumé

BACKGROUND
Some patients have severe aortic valve stenosis (AS) despite a lower degree of aortic valve calcification (AVC). This study compared the clinical features and prognosis of patients undergoing aortic valve replacement (AVR) for severe AS with a low AVC score compared with those with higher AVC scores.
METHODS
This study included 1002 Korean patients with symptomatic severe degenerative AS who underwent AVR. We measured AVC score before AVR and defined low AVC as AVC score of <2000 units for male patients and <1300 units for female patients. Patients with bicuspid or rheumatic aortic valve disease were excluded.
RESULTS
The mean age was 75.6±7.9 years and 487 patients (48.6%) were female. Mean left ventricular ejection fraction was 59.4%±10.4%, and concomitant coronary revascularisation was performed in 96 patients (9.6%). The median aortic valve calcium score was 3122 units (IQR 2249-4289 units) among male patients and 1756 units (IQR 1192-2572) among female patients. A total of 242 patients (24.2%) had low AVC; they were significantly younger (73.5±8.7 years vs 76.3±7.5 years, p<0.001) and were more likely to be female (59.5% vs 45.1%, p<0.001) and on haemodialysis (5.4% vs 1.8%, p=0.006) than those with high AVC. During a follow-up (median: 3.8 years), the patients with low AVC had significantly higher risk of death from any cause (adjusted HR 1.60, 95% CI 1.02 to 2.52, p=0.04), mostly non-cardiac cause.
CONCLUSIONS
Patients with low AVC exhibit distinct clinical characteristics and a higher risk of long-term mortality compared with those with high AVC.

Identifiants

pubmed: 37290900
pii: heartjnl-2023-322435
doi: 10.1136/heartjnl-2023-322435
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1479-1485

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: DHY, the corresponding author of this paper, is an editorial board member for BMJ Heart.

Auteurs

Yeonwoo Choi (Y)

Division of Cardiology, Asan Medical Center, Seoul, South Korea.

Jung-Min Ahn (JM)

Division of Cardiology, Asan Medical Center, Seoul, South Korea drjmahn@gmail.com donghyun.yang@gmail.com.

Dong Hyun Yang (DH)

Department of Radiology, Asan Medical Center, Seoul, South Korea drjmahn@gmail.com donghyun.yang@gmail.com.

Hyun Jung Koo (HJ)

Department of Radiology, Asan Medical Center, Seoul, South Korea.

Seung-Ah Lee (SA)

Division of Cardiology, Asan Medical Center, Seoul, South Korea.

Do-Yoon Kang (DY)

Division of Cardiology, Asan Medical Center, Seoul, South Korea.

Joon Bum Kim (JB)

Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Seoul, South Korea.

Duk-Woo Park (DW)

Division of Cardiology, Asan Medical Center, Seoul, South Korea.

Dae-Hee Kim (DH)

Division of Cardiology, Asan Medical Center, Seoul, South Korea.

Suk Jung Choo (SJ)

Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Seoul, South Korea.

Seung-Jung Park (SJ)

Division of Cardiology, Asan Medical Center, Seoul, South Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH